ClinConnect ClinConnect Logo
Search / Trial NCT03627923

Personalizing Mediterranean Diet in Children.

Launched by WEIZMANN INSTITUTE OF SCIENCE · Aug 13, 2018

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Postprandial Glucose Response Mediterranean Diet Personalized Nutrition

ClinConnect Summary

This clinical trial, titled "Personalizing Mediterranean Diet in Children," is studying how different diets affect blood sugar levels in healthy children. The goal is to learn how to create personalized diet plans based on each child's unique response to food. Researchers will collect information from blood tests, personal habits, and gut bacteria to develop a tailored Mediterranean diet that could help prevent health issues like obesity and other diseases later in life.

To be eligible for this study, children must be healthy, between 6 and 11 years old, and at a specific stage of development known as Tanner 1. Unfortunately, children with recent serious illnesses, certain chronic health conditions, or who are taking specific medications won't be able to participate. If selected, children will have the chance to take part in a program that involves using a smartphone app to track their diet and health, helping researchers gather important information to create these personalized diet recommendations.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Healthy children
  • 6-11 years of age
  • Tanner 1
  • • Exclusion criteria:
  • Acute disease 2 months prior to enrollment
  • Chronic illness in the past 5 years, including inflammatory, metabolic, neoplastic, congenital and infectious disease.
  • Use of medications (e.g. Antibiotics/antifungal, PPI, analgesics) and any antibiotics 3 months prior to the first visit, PPI one month prior to the beginning of the study or use of medication during the study.
  • Treatment with anti-diabetic medications;
  • Neuro-psychiatric disorders
  • Cancer and recent anticancer treatment
  • Eating disorders (Anorexia nervosa. Bulimia nervosa. Binge eating disorder, Night eating syndrome).
  • Inability of the participant and/or nuclear family to follow and utilize the smartphone application.
  • Dietary restrictions or specific dietary regimen

About Weizmann Institute Of Science

The Weizmann Institute of Science is a prestigious research institution located in Rehovot, Israel, renowned for its interdisciplinary approach to scientific inquiry. Established in 1934, the Institute is dedicated to advancing knowledge across various fields, including biology, chemistry, physics, and mathematics. Its cutting-edge research and innovation extend to clinical trials, where it collaborates with global partners to translate scientific discoveries into therapeutic applications. The Weizmann Institute's commitment to excellence in research and education makes it a leading sponsor of clinical trials aimed at improving human health and understanding complex biological processes.

Locations

Reẖovot, , Israel

Patients applied

0 patients applied

Trial Officials

Eran Elinav, Prof

Principal Investigator

Weizmann Institute of Science

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials